TeenaBhatlaMD
Pediatric Hematology & Oncology • New York, NYPediatric Anemia and Red Blood Cell Hematology, Pediatric Hematologic Oncology, Pediatric Solid Tumor Oncology
Director, The Valerie Fund Children's Center for Cancer and blood disorder, Division of Pediatric Hematology-oncology, Department of Pediatrics, Children's Hospital of New Jersey at Newark Beth Israel Medical Center
Dr. Bhatla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 1st Ave
New York, NY 10016
Summary
- Dr. Teena Bhatla is a pediatric hematologist/oncologist in Newark, NJ and is affiliated with multiple hospitals in the area, including Newark Beth Israel Medical Center, Newark Beth Israel Medical Center, and Saint Barnabas Medical Center. She received her medical degree from Sawai Man Singh Medical College and has been in practice 16 years. She specializes in pediatric anemia and red blood cell hematology, pediatric hematologic oncology, and pediatric solid tumor oncology and is experienced in pediatric hematology and oncology and pediatric red blood cell hematology.
Education & Training
NYU Grossman School of MedicineFellowship, Pediatric Hematology/Oncology, 2008 - 2011
Maimonides Medical Center/Infants and Children's Hospital of BrooklynResidency, Pediatrics, 2006 - 2008
Sawai Man Singh Medical CollegeClass of 2001
Certifications & Licensure
NJ State Medical License 2018 - 2025
NY State Medical License 2013 - 2018
MI State Medical License 2008 - 2009- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Start of enrollment: 2019 Jul 03
Publications & Presentations
PubMed
- 73 citationsCharacterization of COVID-19 disease in pediatric oncology patients: The New York-New Jersey regional experience.P. Pallavi Madhusoodhan, Joanna Pierro, Jordan Musante, Prachi Kothari, Bradley Gampel
Pediatric Blood & Cancer. 2021-03-01 - 24 citationsDecitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samplesBenjamin Y. Lu, Shivani U. Thanawala, Kelly C Zochowski, Michael J. Burke, William L. Carroll
Leukemia & Lymphoma. 2016-01-04 - 108 citationsEpigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia.Teena Bhatla, Jinhua Wang, Debra J. Morrison, Elizabeth A. Raetz, Michael J. Burke
Blood. 2012-05-31
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
